相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sorafenib for hepatocellular carcinoma: potential molecular targets and resistance mechanisms
Mandeep Dahiya et al.
JOURNAL OF CHEMOTHERAPY (2022)
lncRNA-POIR promotes epithelial-mesenchymal transition and suppresses sorafenib sensitivity simultaneously in hepatocellular carcinoma by sponging miR-182-5p
Bryan Wei Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2021)
The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma
Lika Gamaev et al.
ONCOGENE (2021)
The role of autophagy in pancreatic cancer progression
Yuanyang Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
H19 Promotes HCC Bone Metastasis Through Reducing Osteoprotegerin Expression in a Protein Phosphatase 1 Catalytic Subunit Alpha/p38 Mitogen-Activated Protein Kinase-Dependent Manner and Sponging microRNA 200b-3p
Zhao Huang et al.
HEPATOLOGY (2021)
Extracellular HMGB1 promotes CD44 expression in hepatocellular carcinoma via regulating miR-21
Jun Li et al.
Aging-US (2021)
The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer
Yu Wang et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2021)
The Risks of miRNA Therapeutics: In a Drug Target Perspective
Song Zhang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2021)
Upregulation of miR-138 Increases Sensitivity to Cisplatin in Hepatocellular Carcinoma by Regulating EZH2
Taohui Zeng et al.
BIOMED RESEARCH INTERNATIONAL (2021)
Emerging Role of MiR-192-5p in Human Diseases
Fu-jia Ren et al.
FRONTIERS IN PHARMACOLOGY (2021)
MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K/AKT, TGF-β, and STAT3 Signaling
Chi-Yu Lai et al.
CANCERS (2021)
MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation
Yinghui Hong et al.
FRONTIERS IN ONCOLOGY (2021)
Exosomal microRNAs as Biomarkers and Therapeutic Targets for Hepatocellular Carcinoma
Andrei Sorop et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
Yu-Yun Shao et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2021)
miRNA activity inferred from single cell mRNA expression
Morten Muhlig Nielsen et al.
SCIENTIFIC REPORTS (2021)
microRNA-based diagnostic and therapeutic applications in cancer medicine
Lorenzo F. Sempere et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2021)
The Challenges and Strategies of Antisense Oligonucleotide Drug Delivery
Maria Gagliardi et al.
BIOMEDICINES (2021)
The Mechanisms of HBV-Induced Hepatocellular Carcinoma
Yu Jiang et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2021)
Long non-coding RNA HCP5 functions as a sponge of miR-29b-3p and promotes cell growth and metastasis in hepatocellular carcinoma through upregulating DNMT3A
Yongping Zhou et al.
AGING-US (2021)
Dietary daidzein inhibits hepatitis C virus replication by decreasing microRNA-122 levels
Yujiao He et al.
VIRUS RESEARCH (2021)
Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition
Na Zhao et al.
NATURE COMMUNICATIONS (2021)
MicroRNA-138-1-3p sensitizes sorafenib to hepatocellular carcinoma by targeting PAK5 mediated β-catenin/ABCB1 signaling pathway
Tong-tong Li et al.
JOURNAL OF BIOMEDICAL SCIENCE (2021)
miR-26b enhances the sensitivity of hepatocellular carcinoma to Doxorubicin via USP9X-dependent degradation of p53 and regulation of autophagy
Enjiang Chen et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
MicroRNA-214 suppresses cell proliferation and migration and cell metabolism by targeting PDK2 and PHF6 in hepatocellular carcinoma
Qiangfeng Yu et al.
CELL BIOLOGY INTERNATIONAL (2020)
miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy
Wen-Ping Xu et al.
GUT (2020)
Mechanisms of lncRNA/microRNA interactions in angiogenesis
Zhuo Zhao et al.
LIFE SCIENCES (2020)
Silencing of lncRNA PVT1 by miR-214 inhibits the oncogenic GDF15 signaling and suppresses hepatocarcinogenesis
Xiangyu Xiong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Gut microbiome in HCC - Mechanisms, diagnosis and therapy
Robert F. Schwabe et al.
JOURNAL OF HEPATOLOGY (2020)
Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage
Ping Luo et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
Randomized clinical trials towards a single-visit cure for chronic hepatitis C: Oral GSK2878175 and injectable RG-101 in chronic hepatitis C patients and long-acting injectable GSK2878175 in healthy participants
Yanli Deng et al.
JOURNAL OF VIRAL HEPATITIS (2020)
RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
Sarah Bajan et al.
CELLS (2020)
miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis
Carmen Elena Condrat et al.
CELLS (2020)
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
David S. Hong et al.
BRITISH JOURNAL OF CANCER (2020)
miR-206 inhibits liver cancer stem cell expansion by regulating EGFR expression
Caifeng Liu et al.
CELL CYCLE (2020)
Challenges identifying efficacious miRNA therapeutics for cancer
Meirav Segal et al.
EXPERT OPINION ON DRUG DISCOVERY (2020)
Medical oncology management of advanced hepatocellular carcinoma 2019: a reality check
Amy Lee et al.
FRONTIERS OF MEDICINE (2020)
Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma
Pornpitra Pratedrat et al.
PLOS ONE (2020)
The role of cancer-derived microRNAs in cancer immune escape
Ming Yi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR
Ji Lin et al.
CELL DEATH & DISEASE (2020)
Clinical significance of combined circulating TERT promoter mutations and miR-122 expression for screening HBV-related hepatocellular carcinoma
Ngo Tat Trung et al.
SCIENTIFIC REPORTS (2020)
Circulating MicroRNA-122 for the Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis
Xiao-Fei Zhao et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Long non-coding RNA H19 is involved in sorafenib resistance in hepatocellular carcinoma by upregulating miR-675
Yongzi Xu et al.
ONCOLOGY REPORTS (2020)
The alpha-fetoprotein serum is still reliable as a biomarker for the surveillance of hepatocellular carcinoma in Indonesia
Chyntia Olivia Maurine Jasirwan et al.
BMC GASTROENTEROLOGY (2020)
miR-103a-3p Could Attenuate Sepsis-Induced Liver Injury by Targeting HMGB1
Leifeng Chen et al.
INFLAMMATION (2020)
MicroRNA Biomarkers for Infectious Diseases: From Basic Research to Biosensing
Leon Tribolet et al.
FRONTIERS IN MICROBIOLOGY (2020)
A Comprehensive Review of Cancer MicroRNA Therapeutic Delivery Strategies
Alexis Forterre et al.
CANCERS (2020)
MicroRNAs Modulate Drug Resistance-Related Mechanisms in Hepatocellular Carcinoma
Yuehui Liang et al.
FRONTIERS IN ONCOLOGY (2020)
Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p/CDK6 axis
Chao Lin et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2020)
Advances in oligonucleotide drug delivery
Thomas C. Roberts et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
miR-124 regulates liver cancer stem cells expansion and sorafenib resistance
Yun Feng et al.
EXPERIMENTAL CELL RESEARCH (2020)
Various miRNAs compensate the role of miR-122 on HCV replication
Chikako Ono et al.
PLOS PATHOGENS (2020)
Potential role of miR-214 in β-catenin gene expression within hepatocellular carcinoma
Hamzeh Karimkhanloo et al.
MOLECULAR BIOLOGY REPORTS (2020)
LncRNA CRNDE facilitates epigenetic suppression of CELF2 and LATS2 to promote proliferation, migration and chemoresistance in hepatocellular carcinoma
Shu-Cai Xie et al.
CELL DEATH & DISEASE (2020)
Hepatic miR-192-3p reactivation alleviates steatosis by targeting glucocorticoid receptor
Zhangting Wang et al.
JHEP REPORTS (2020)
Upregulation of miR-124-3p by Liver X Receptor Inhibits the Growth of Hepatocellular Carcinoma Cells Via Suppressing Cyclin D1 and CDK6
Dan Zhong et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2020)
Targeted therapy for hepatocellular carcinoma
Ao Huang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Therapeutic siRNA: state of the art
Bo Hu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Overexpression of microRNA-9 enhances cisplatin sensitivity in hepatocellular carcinoma by regulating EIF5A2-mediated epithelial-mesenchymal transition
Ying Bao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
MiR-17-92 cluster and immunity
George Kuo et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2019)
Circulating liver-specific microRNAs as noninvasive diagnostic biomarkers of hepatic diseases in human
Ghulam Musaddaq et al.
BIOMARKERS (2019)
MicroRNA Detection Specificity: Recent Advances and Future Perspective
Tinglan Ouyang et al.
ANALYTICAL CHEMISTRY (2019)
Deregulation of SATB2 in carcinogenesis with emphasis on miRNA-mediated control
Qiao Yi Chen et al.
CARCINOGENESIS (2019)
MicroRNA profiling from dried blood samples
Caroline Diener et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2019)
miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway
Fei Cao et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2019)
miR-206 inhibits cell proliferation, invasion, and migration by down-regulating PTP1B in hepatocellular carcinoma
Qian Yang et al.
BIOSCIENCE REPORTS (2019)
miR-194 inhibits liver cancer stem cell expansion by regulating RAC1 pathway
Rong-Zheng Ran et al.
EXPERIMENTAL CELL RESEARCH (2019)
TNRC6 proteins modulate hepatitis C virus replication by spatially regulating the binding of miR-122/Ago2 complexes to viral RNA
You Li et al.
NUCLEIC ACIDS RESEARCH (2019)
Impact of a patient-derived hepatitis C viral RNA genome with a mutated microRNA binding site
Miguel Mata et al.
PLOS PATHOGENS (2019)
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma
Cristian Turato et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Hepatitis C Virus Infection Induces Hepatic Expression of NF-kappa B-Inducing Kinase and Lipogenesis by Downregulating miR-122
Brianna Lowey et al.
MBIO (2019)
Epithelial-to-mesenchymal transition and drug resistance: transitioning away from death
Kyung-A Song et al.
JOURNAL OF THORACIC DISEASE (2019)
Circulating MicroRNAs in Cancer: Potential and Challenge
Mengying Cui et al.
FRONTIERS IN GENETICS (2019)
New promising circulating RNA biomarkers for early diagnosis of lung adenocarcinoma
Francisco J. Enguita
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Diagnostic value of circulating miRNA-122 for hepatitis B virus and/or hepatitis C virus-associated chronic viral hepatitis
Xinhao Zhou et al.
BIOSCIENCE REPORTS (2019)
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
MicroRNA regulation in colorectal cancer tissue and serum
Lukasz Gmerek et al.
PLOS ONE (2019)
Mechanism of miR-107-targeting of regulator of G-protein signaling 4 in hepatocellular carcinoma
Di Xiao et al.
ONCOLOGY LETTERS (2019)
The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma
Ling Wei et al.
MOLECULAR CANCER (2019)
miR-223 overexpression inhibits doxorubicin-induced autophagy by targeting FOXO3a and reverses chemoresistance in hepatocellular carcinoma cells
Yue Zhou et al.
CELL DEATH & DISEASE (2019)
MiR-26b suppresses hepatocellular carcinoma development by negatively regulating ZNRD1 and Wnt/β-catenin signaling
Xiaobo Hu et al.
CANCER MEDICINE (2019)
The role of microRNA in the resistance to treatment of hepatocellular carcinoma
Muhammad Yogi Pratama et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
MicroRNA-26b-5p enhances T cell responses by targeting PIM-2 in hepatocellular carcinoma
Wenjie Han et al.
CELLULAR SIGNALLING (2019)
Why have microRNA biomarkers not been translated from bench to clinic?
Kioomars Saliminejad et al.
FUTURE ONCOLOGY (2019)
MicroRNA amplification and detection technologies: opportunities and challenges for point of care diagnostics
Vivek Priy Dave et al.
LABORATORY INVESTIGATION (2019)
MiRNA-206 inhibits hepatocellular carcinoma cell proliferation and migration but promotes apoptosis by modulating cMET expression
Yuanxi Wang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2019)
Expression Analysis of MicroRNA-21 and MicroRNA-122 in Hepatocellular Carcinoma
Dipu Bharali et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2019)
MicroRNA-122 in patients with hepatitis B and hepatitis B virus-associated hepatocellular carcinoma
Mohammad Reza Mahmoudian-Sani et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)
Selecting analytical biomarkers for diagnostic applications: a first principles approach
Samantha A. Byrnes et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)
MiR-199-3p replacement affects E-cadherin expression through Notch1 targeting in hepatocellular carcinoma
Catia Giovannini et al.
ACTA HISTOCHEMICA (2018)
DCAF1 is involved in HCV replication through regulation of miR-122
Yanling Yan et al.
ARCHIVES OF VIROLOGY (2018)
MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice
Yongxia Wu et al.
BLOOD (2018)
MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-1/Smad3 pathway in hepatic stellate cells
Xiao Feili et al.
CELL BIOLOGY INTERNATIONAL (2018)
MicroRNA-199 suppresses cell proliferation, migration and invasion by downregulating RGS17 in hepatocellular carcinoma
Wei Zhang et al.
GENE (2018)
Hepatoma cell-secreted exosomal microRNA-103 increases vascular permeability and promotes metastasis by targeting junction proteins
Jian-Hong Fang et al.
HEPATOLOGY (2018)
The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity
Florian Schueller et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Decreased levels of serum exosomal miR-638 predict poor prognosis in hepatocellular carcinoma
Min Shi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway
Xiao Fu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma
Ngo Tat Trung et al.
PLOS ONE (2018)
Upregulation of microRNA-32 is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma
Huiqiong Yang et al.
ONCOLOGY LETTERS (2018)
Serum exosomal microRNA-122 and microRNA-21 as predictive biomarkers in transarterial chemoembolization-treated hepatocellular carcinoma patients
Tomoyuki Suehiro et al.
ONCOLOGY LETTERS (2018)
Nanotechnology based approaches for detection and delivery of microRNA in healthcare and crop protection
Vrantika Chaudhary et al.
JOURNAL OF NANOBIOTECHNOLOGY (2018)
Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
Lan Thi Hanh Phi et al.
STEM CELLS INTERNATIONAL (2018)
Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma
Yurong Wang et al.
CANCER MEDICINE (2018)
Non-coding RNA in drug resistance of hepatocellular carcinoma
Bisha Ding et al.
BIOSCIENCE REPORTS (2018)
Biology of MiR-17-92 Cluster and Its Progress in Lung Cancer
Xinju Zhang et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2018)
Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease
Jorge-Luis Torres et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Low expression of miR-199 in hepatocellular carcinoma contributes to tumor cell hyper-proliferation by negatively suppressing XBP1
Zheng Lou et al.
ONCOLOGY LETTERS (2018)
The Correlation between miR-122 and Lipoprotein Lipase Expression in Chronic Hepatitis C Patients
Malgorzata Sidorkiewicz et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
Jacob O'Brien et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
miR-103 promotes the metastasis and EMT of hepatocellular carcinoma by directly inhibiting LATS2
Li-Li Han et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Staging systems of hepatocellular carcinoma: A review
Sreeshma Tellapuri et al.
INDIAN JOURNAL OF GASTROENTEROLOGY (2018)
Possible Role of microRNA-122 in Modulating Multidrug Resistance of Hepatocellular Carcinoma
Shaymaa M. M. Yahya et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2018)
Inducing Hepatitis C Virus Resistance After Pig Liver Transplantation-A Proof of Concept of Liver Graft Modification Using Warm Ex Vivo Perfusion
N. Goldaracena et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
microRNA-122 target sites in the hepatitis C virus RNA NS5B coding region and 3' untranslated region: function in replication and influence of RNA secondary structure
Gesche K. Gerresheim et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease
Yaron Rotman et al.
GUT (2017)
Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
Muhammad S. Beg et al.
INVESTIGATIONAL NEW DRUGS (2017)
miR-107-mediated decrease of HMGCS2 indicates poor outcomes and promotes cell migration in hepatocellular carcinoma
Shu-Guang Su et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2017)
Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma
Weifeng Liu et al.
ONCOTARGETS AND THERAPY (2017)
MiR-199a/b-5p inhibits hepatocellular carcinoma progression by post-transcriptionally suppressing ROCK1
Yangyang Zhan et al.
ONCOTARGET (2017)
Implications of MicroRNAs in Oncolytic Virtherapy
Xavier Bofill-De Ros et al.
FRONTIERS IN ONCOLOGY (2017)
Stability of Circulating Blood-Based MicroRNAs - Pre-Analytic Methodological Considerations
Charlotte Glinge et al.
PLOS ONE (2017)
MicroRNA pharmacogenomics based integrated model of miR-17-92 cluster in sorafenib resistant HCC cells reveals a strategy to forestall drug resistance
Faryal Mehwish Awan et al.
SCIENTIFIC REPORTS (2017)
Thyroid hormone inhibits growth of hepatoma cells through induction of miR-214
Po-Shuan Huang et al.
SCIENTIFIC REPORTS (2017)
Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II
Gian Paolo Caviglia et al.
PANMINERVA MEDICA (2017)
The miR-491-3p/Sp3/ABCB1 axis attenuates multidrug resistance of hepatocellular carcinoma
Yang Zhao et al.
CANCER LETTERS (2017)
Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing
Meike H. van der Ree et al.
ANTIVIRAL RESEARCH (2017)
Elevated Preoperative Serum CEA Level Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma Through the Epithelial-Mesenchymal Transition
Masato Yoshikawa et al.
ANTICANCER RESEARCH (2017)
MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways
Yanmin Xu et al.
CANCER LETTERS (2016)
Is miR-34a a Well-equipped Swordsman to Conquer Temple of Molecular Oncology?
Ammad Ahmad Farooqi et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2016)
Enhanced expression of hepatocyte-specific microRNAs in valproic acid mediated hepatic trans-differentiation of human umbilical cord derived mesenchymal stem cells
Akshata Raut et al.
EXPERIMENTAL CELL RESEARCH (2016)
MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions
Caterina Catalanotto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology
Daniel W. Binzel et al.
MOLECULAR THERAPY (2016)
Endogenous microRNA sponges: evidence and controversy
Daniel W. Thomson et al.
NATURE REVIEWS GENETICS (2016)
Tumor Heterogeneity in Hepatocellular Carcinoma: Facing the Challenges
Li-Chun Lu et al.
LIVER CANCER (2016)
Heterogeneity of hepatocellular carcinoma contributes to cancer progression
Kuo-Shyang Jeng et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
Identification of Endogenous Controls for Analyzing Serum Exosomal miRNA in Patients with Hepatitis B or Hepatocellular Carcinoma
Yi Li et al.
DISEASE MARKERS (2015)
MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN
Shi-yan Yan et al.
TUMOR BIOLOGY (2015)
Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases
Jason Lamontagne et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
MiR-200b/200c/429 subfamily negatively regulates Rho/ROCK signaling pathway to suppress hepatocellular carcinoma metastasis
Chun-Ming Wong et al.
ONCOTARGET (2015)
MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway
Changjun He et al.
ONCOTARGET (2015)
Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC
Francesca Fornari et al.
PLOS ONE (2015)
Technology in MicroRNA Profiling: Circulating MicroRNAs as Noninvasive Cancer Biomarkers in Breast Cancer
Fernando Pimentel et al.
JALA (2015)
Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients
Meike H. van der Ree et al.
ANTIVIRAL RESEARCH (2014)
miRNA in Plasma Exosome is Stable under Different Storage Conditions
Qinyu Ge et al.
MOLECULES (2014)
Therapeutic targeting of microRNAs: current status and future challenges
Zhonghan Li et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Miravirsen (SPC3649) can inhibit the biogenesis of miR-122
Luca F. R. Gebert et al.
NUCLEIC ACIDS RESEARCH (2014)
Identification of microRNAs specifically expressed in hepatitis C virus-associated hepatocellular carcinoma
Giacomo Diaz et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Purification and microRNA Profiling of Exosomes Derived from Blood and Culture Media
Marguerite K. McDonald et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2013)
Analysis of Circulating MicroRNA: Preanalytical and Analytical Challenges
Jennifer S. McDonald et al.
CLINICAL CHEMISTRY (2011)
Chemical modification and design of anti-miRNA oligonucleotides
K. A. Lennox et al.
GENE THERAPY (2011)
Oligomeric Nucleic Acids as Antivirals
Alessandra Mescalchin et al.
MOLECULES (2011)
MicroRNAs 103 and 107 regulate insulin sensitivity
Mirko Trajkovski et al.
NATURE (2011)
Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer
G. Mudduluru et al.
ONCOGENE (2011)
Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells
Maria Mittelbrunn et al.
NATURE COMMUNICATIONS (2011)
Chemotherapy with etoposide, doxorubicin, cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma
Jeng-Nian Yuan et al.
MEDICAL ONCOLOGY (2008)
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Nader Rifai et al.
NATURE BIOTECHNOLOGY (2006)
Genetics of hepatocellular tumors
P. Laurent-Puig et al.
ONCOGENE (2006)
The Drosha-DGCR8 complex in primary microRNA processing
JJ Han et al.
GENES & DEVELOPMENT (2004)
分享论文
